Terms: = Pancreatic cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Staging
4 results:
1. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.
Wei D; Zaid MM; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Agrawal A; Rashid A; Wang H; Varadhachary G; Wolff RA; Tamm EP; Bhosale PR; Maitra A; Koay EJ; Wang H
Pancreatology; 2021 Jan; 21(1):200-207. PubMed ID: 33221151
[TBL] [Abstract] [Full Text] [Related]
2. A qualitative transcriptional prognostic signature for patients with stage I-II pancreatic ductal adenocarcinoma.
Huang H; Zou Y; Zhang H; Li X; Li Y; Deng X; Sun H; Guo Z; Ao L
Transl Res; 2020 May; 219():30-44. PubMed ID: 32119844
[TBL] [Abstract] [Full Text] [Related]
3. Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma.
Allen PJ; Chou J; Janakos M; Strong VE; Coit DG; Brennan MF
Ann Surg Oncol; 2011 Mar; 18(3):636-41. PubMed ID: 20953910
[TBL] [Abstract] [Full Text] [Related]
4. Utility of tumor markers in determining resectability of pancreatic cancer.
Schlieman MG; Ho HS; Bold RJ
Arch Surg; 2003 Sep; 138(9):951-5; discussion 955-6. PubMed ID: 12963650
[TBL] [Abstract] [Full Text] [Related]
